GRN and cancer: Increased GRN serum or tissue levels, in contrast, were associated with cancer and connected to a negative prognosis, for example in carcinomas of the breast [57,58,59], ovary [60], liver [61], prostate [62], and lung [63], and in brain tumors like glioblastoma [64].